InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by PERRY DAVID P, Autre. Officer active across 1 company, notably Better Therapeutics, Inc.. Aggregated, 7 disclosures have been published. Split: 4 buys · 0 sell. History available since 18 December 2023. The latest transaction was disclosed on 18 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
839,895 shares@ €0.17686.6% of flowCommon StockSEC:0000950170-24-014898:0
1,471,453 shares@ €0.155110.1% of flowCommon StockSEC:0000950170-24-003637:0
3,750 shares0Common StockSEC:0000950170-23-071963:0
1,233,045 shares@ €0.664836.2% of flowCommon StockSEC:0000950170-23-035685:0
Canonical exit: 25 Oct 2023 (T+90)
1,333,333 shares@ €0.75944.7% of flowCommon StockSEC:0000899243-23-011231:0
Canonical exit: 9 Jul 2023 (T+90)
10,844 shares@ €1.99631.0% of flowCommon StockSEC:0000899243-22-031420:0
Canonical exit: 14 Dec 2022 (T+90)
2,000 shares@ €8.204850.0% of flowCommon StockSEC:0000899243-21-042250:0
Canonical exit: 29 Jul 2021 (T+90)
7 of 7 declarations
About PERRY DAVID P
David P. Perry is involved in various functions at Better Therapeutics, Inc. His role is essential in supporting the company's strategic initiatives and contributing to its development in the healthcare sector.
